Atlas Trials

Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis

Clinical trial NCT06414512 · COMPLETED

Trial details

NCT number
NCT06414512
Sponsor
University of Minnesota
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cryptococcal Meningitis
Start date
2024-04-09
Primary completion
2024-10-02
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.